Locations
New Haven, CT, USA · Farmington, CT, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2018
Rallybio is a clinical-stage biotech company focused on developing transformative therapies for patients with rare diseases. The company aims to address significant unmet medical needs, particularly in areas such as hematology, immuno-inflammation, maternal-fetal health, and metabolic disorders. Rallybio's innovative approach combines a strong team with extensive experience in drug discovery and development, leveraging partnerships and scientific advancements to bring new therapies to market. Their pipeline includes multiple promising product candidates, with a commitment to delivering impactful solutions for patients suffering from severe conditions.
Something looks off?